key: cord-0958487-jl60m1o3 authors: Richardson, Joshua E; Alper, Brian S; Lehmann, Harold P; Subbian, Vignesh title: It is time for computable evidence synthesis: The COVID-19 Knowledge Accelerator Initiative date: 2020-05-22 journal: J Am Med Inform Assoc DOI: 10.1093/jamia/ocaa114 sha: 3abf943d4189a154a7603183fe88e55782b1f4c5 doc_id: 958487 cord_uid: jl60m1o3 nan IT IS TIME FOR COMPUTABLE EVIDENCE SYNTHESIS 4 opportunity to accelerate development and interoperability of many systems to realize the aspirations of computable evidence synthesis. In this letter, we describe the origins and status of the COVID-19 Knowledge Accelerator (COKA). There are tremendous inefficiencies in our current scientific dissemination systems in which many researchers compute the results then convert it to various non-computable forms for human-readable displays, then many other knowledge processors work with the various humanreadable displays to extract the data and enter it into computable form for evidence synthesis. This inefficient pattern is repeated incrementally across multiple steps in an extended series of processes while reports are re-evaluated and re-used in subsequent reports. Thus, Structured (computable) results directly from research and research publications would greatly accelerate evidence synthesis. Trial registries such as ClinicalTrials.gov are a good place for identifying early system developments for processing structured results data, but structured results data would be especially useful as a companion to scholarly publications, preprint publications, and derivative works where systematic reviewers and other evidence processors are evaluating currently unstructured results data. For example, COVID-19 studies have already resulted in hundreds of systematic reviews. Achieving a state of structured results data as standard practice will not likely occur through a single universal repository, but we believe it can be achieved with universal standards for data exchange, and multiple component standards which account for the many types of data that represent and support research results. Several groups-including the Guidelines International Network-seeking to accelerate evidence synthesis through collaborations set out to define standards for computable expressions In response to these requests, our group initiated the COVID-19 Knowledge Accelerator (COKA, https://www.gps.health/covid19_knowledge_accelerator.html). The specific strategy of COKA is to establish universal standards for each component of knowledge exchanged and thus enable stakeholders to share and re-use their efforts by using the same format for electronic data exchange. As of May 11, 2020, COKA had 50 working meetings with more than 40 active participants from more than 25 organizations from academia, industry, government, and nonhttps://mc.manuscriptcentral.com/jamia IT IS TIME FOR COMPUTABLE EVIDENCE SYNTHESIS 6 profits in seven countries. The group has created additional draft FHIR standards for expressions of Citations (http://build.fhir.org/citation.html) and Evidence Reports (http://build.fhir.org/evidencereport.html) that provide compositions of all the preceding concepts. We strongly encourage developers of systems for evidence identification, evaluation, and dissemination to use these resources now as foundational elements to create a computational evidence ecosystem. This environment includes the building blocks for achieving computable evidence synthesis. Other resources not noted above, such as resources for computational logic expressions, may ultimately be needed for the complete ecosystem. If we can develop standards for each granular component, we can then weave together the many overlapping systems and consortia to accelerate realization of this complex evidence ecosystem. Computable evidence synthesis is not the endpoint but rather another step in a larger knowledge ecosystem. For instance, the EBMonFHIR project is closely related to a CPGonFHIR Although creating a computational environment for evidence could be done for any domain or subject matter, 4,5 COVID-19 currently presents a unique human interest with urgency and impact, thus providing a special openness to collaboration. We invite your participation at https://www.gps.health/covid19_knowledge_accelerator.html. https://mc.manuscriptcentral.com/jamia Is it time for computable evidence synthesis EBMonFHIR -Clinical Decision Support -Confluence An Informatics Infrastructure Is Essential for Evidence-based Practice Mind the Gap: Putting Evidence into Practice in the Era of Learning Health Systems HL7 and FHIR are registered trademarks of Health Level Seven International Dr. Alper is employed by an information services company but the COKA and EBMonFHIR efforts are open, noncommercial activities.Drs. Richardson, Lehmann, and Subbian have no competing interests to report. Dr. Subbian is supported in part by the National Science Foundation under grant #1838745 and the Arizona Board of Regents' Technology Research and Innovation Fund (TRIF). All listed authors contributed to this correspondence.